Opa1 Is Required for Proper Mitochondrial Metabolism in Early Development

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Rahn, Jennifer J ^a   Stackley, Krista D ^a   Chan, Sherine S L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MORPHOLINO OLIGONUCLEOTIDE; PROTEIN OPA1; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EMBRYO; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; BIOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE DELETION; GENE EXPRESSION REGULATION; MITOCHONDRIAL GENETICS; MITOCHONDRIAL RESPIRATION; NONHUMAN; OPA1 GENE; PHENOTYPIC VARIATION; PROTEIN DEPLETION; PROTEIN FUNCTION; STARTLE REFLEX; UPREGULATION; WESTERN BLOTTING; ZEBRA FISH;

ANIMALS; BLOTTING, WESTERN; MITOCHONDRIA; MORPHOLINOS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84875010856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059218     Document Type: Article

References (54)

1. Suen DF, Norris KL, Youle RJ, (2008) Mitochondrial dynamics and apoptosis. Genes Dev 22: 1577-1590.
2. van der Bliek AM, (2009) Fussy mitochondria fuse in response to stress. EMBO J 28: 1533-1534.
3. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, et al. (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126: 177-189.
4. Olichon A, Elachouri G, Baricault L, Delettre C, Belenguer P, et al. (2007) OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ 14: 682-692.
5. Olichon A, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, et al. (2007) Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 211: 423-430.
6. Chen H, Chomyn A, Chan DC, (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280: 26185-26192.
7. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, et al. (2010) Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141: 280-289.
8. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, et al. (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26: 207-210.
9. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, et al. (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26: 211-215.
10. Ferre M, Amati-Bonneau P, Tourmen Y, Malthiery Y, Reynier P, (2005) eOPA1: an online database for OPA1 mutations. Hum Mutat 25: 423-428.
11. Kim JY, Hwang JM, Ko HS, Seong MW, Park BJ, et al. (2005) Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology 64: 966-972.
12. Ranieri M, Del Bo R, Bordoni A, Ronchi D, Colombo I, et al. (2012) Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families. J Neurol Sci 315: 146-149.
13. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, et al. (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 131: 338-351.
14. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, et al. (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131: 329-337.
15. Davies VJ, Hollins AJ, Piechota MJ, Yip W, Davies JR, et al. (2007) Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 16: 1307-1318.
16. Alavi MV, Fuhrmann N, Nguyen HP, Yu-Wai-Man P, Heiduschka P, et al. (2009) Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Exp Neurol 220: 404-409.
17. Williams PA, Morgan JE, Votruba M, (2010) Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 133: 2942-2951.
18. Veldman MB, Lin S, (2008) Zebrafish as a developmental model organism for pediatric research. Pediatr Res 64: 470-476.
19. Liu J, Stainier DY, (2012) Zebrafish in the study of early cardiac development. Circ Res 110: 870-874.
20. Thisse B, Thisse C (2004) Fast Release Clones: A High Throughput Expression Analysis. ZFIN Direct Data Submission. http://zfin.org.
21. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF, (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
22. Kim MJ, Kang KH, Kim CH, Choi SY, (2008) Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. Biotechniques 45: 331-334.
23. Stackley KD, Beeson CC, Rahn JJ, Chan SS, (2011) Bioenergetic profiling of zebrafish embryonic development. PLoS One 6: e25652.
24. Dorn GW, 2nd Clark CF, Eschenbacher WH, Kang MY, Engelhard JT, et al. (2011) MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ Res 108: 12-17.
25. Kanazawa T, Zappaterra MD, Hasegawa A, Wright AP, Newman-Smith ED, et al. (2008) The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals. PLoS Genet 4: e1000022.
26. Williams PA, Morgan JE, Votruba M, (2011) Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss? Vision Res 51: 229-234.
27. Akepati VR, Muller EC, Otto A, Strauss HM, Portwich M, et al. (2008) Characterization of OPA1 isoforms isolated from mouse tissues. J Neurochem 106: 372-383.
28. Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, et al. (2011) OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21: 12-20.
29. Ishihara N, Fujita Y, Oka T, Mihara K, (2006) Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25: 2966-2977.
30. Nunnari J, Suomalainen A, (2012) Mitochondria: in sickness and in health. Cell 148: 1145-1159.
31. Chen L, Gong Q, Stice JP, Knowlton AA, (2009) Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 84: 91-99.
32. Parichy DM, Elizondo MR, Mills MG, Gordon TN, Engeszer RE, (2009) Normal table of postembryonic zebrafish development: staging by externally visible anatomy of the living fish. Dev Dyn 238: 2975-3015.
33. Mendelsohn BA, Kassebaum BL, Gitlin JD, (2008) The zebrafish embryo as a dynamic model of anoxia tolerance. Dev Dyn 237: 1780-1788.
34. Chevrollier A, Guillet V, Loiseau D, Gueguen N, de Crescenzo MA, et al. (2008) Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 63: 794-798.
35. Wallace DC, (1999) Mitochondrial diseases in man and mouse. Science 283: 1482-1488.
36. Teixido E, Pique E, Gomez-Catalan J, Llobet JM (2012) Assessment of developmental delay in the zebrafish embryo teratogenicity assay. Toxicol In Vitro.
37. Stainier DY, Weinstein BM, Detrich HW, 3rd, Zon LI, Fishman MC (1995) Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 121: 3141-3150.
38. Berardelli A, Rothwell JC, Thompson PD, Hallett M, (2001) Pathophysiology of bradykinesia in Parkinson's disease. Brain 124: 2131-2146.
39. Exner N, Lutz AK, Haass C, Winklhofer KF, (2012) Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J 31: 3038-3062.
40. Tondera D, Grandemange S, Jourdain A, Karbowski M, Mattenberger Y, et al. (2009) SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J 28: 1589-1600.
41. Gottlieb RA, Gustafsson AB, (2011) Mitochondrial turnover in the heart. Biochim Biophys Acta 1813: 1295-1301.
42. Ong SB, Hall AR, Hausenloy DJ (2012) Mitochondrial Dynamics in Cardiovascular Health and Disease. Antioxid Redox Signal.
43. Lewis W, Day BJ, Kohler JJ, Hosseini SH, Chan SSL, et al. (2007) MtDNA depletion, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma. J Clin Invest 87: 326-335.
44. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, et al. (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106: 847-856.
45. Chen H, McCaffery JM, Chan DC, (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130: 548-562.
46. Bruni F, Polosa PL, Gadaleta MN, Cantatore P, Roberti M, (2010) Nuclear respiratory factor 2 induces the expression of many but not all human proteins acting in mitochondrial DNA transcription and replication. J Biol Chem 285: 3939-3948.
47. Scarpulla RC, (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88: 611-638.
48. Ylikallio E, Page JL, Xu X, Lampinen M, Bepler G, et al. (2010) Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice. Nucleic Acids Res 38: 8208-8218.
49. Westerfield M (2000) The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). Eugene: University of Oregon Press.
50. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
51. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
52. Bookout AL, Mangelsdorf DJ, (2003) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1: e012.
53. Van Goethem G, Luoma P, Rantamaki M, Al Memar A, Kaakkola S, et al. (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63: 1251-1257.
54. Hunter SE, Jung D, Di Giulio RT, Meyer JN, (2010) The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods 51: 444-451.